Use this URL to cite or link to this record in EThOS:
Title: Development of techniques for verification of advanced radiotherapy by portal dosimetry
Author: Md Radzi, Yasmin
ISNI:       0000 0004 7651 5756
Awarding Body: Cardiff University
Current Institution: Cardiff University
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
This research work is related to the development of an enhanced method for the treatment verification of Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT). Such advanced treatment techniques require accurate verification procedures to ensure treatments are delivered as correctly as possible. This work focused on the use of the Varian aS1000 Electronic Portal Imaging Device (EPID) with Dosimetry Check software-based verification system. This EPID-based patient dose verification had been widely discussed and proposed as a way to achieve treatment delivery accuracy and patient safety, and as an ‘in vivo’ verification technique that helps to avoid or minimise dosimetric errors. In this work, a novel matrix-based software method to correct for backscatter effects from the Varian aS1000 EPID support arm has been developed. The methodology allows a reliable quantification of the backscatter effect to be applied directly to the Dosimetry Check calibration and verification system. This process includes the use of a clinical treatment planning system (Oncentra MasterPlan, Nucletron) to calculate predicted dose distribution within a phantom or patient, which may be compared to the dose reconstructed by Dosimetry Check. It has been demonstrated that the developed method can be applied to both ‘pre-treatment’ and ‘on treatment’ portal dosimetry for IMRT Head-and-Neck. The Gamma Index Method confirmed excellent validation rates of 97% (3%/3mm) and 95% (5%/3mm) for the ‘pre-treatment’ and ‘on treatment’ approach respectively. Pre-treatment verification of VMAT Head-and Neck treatment also reported excellent validation rates of 96% (3%/5mm). In addition, a convenient way to use the developed methodology within Dosimetry Check software was also piloted and tested. This presents an opportunity of future clinical implementation of the techniques developed in this investigation.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available